Home
About
Pricing
Log In
Back
CNR

This asset is not currently listed on any markets available through Pearler. The information on this page may be inaccurate or out of date.

Asset Logo

Cannon Resources Limited

๐Ÿ‡ฆ๐Ÿ‡บ ASX

๐Ÿ‘‘ Overview

๐Ÿ“ˆ Performance

๐Ÿ’ต Cost

๐Ÿƒ Esg

๐Ÿค“ Advanced

๐Ÿ‘จโ€๐Ÿ‘ฉโ€๐Ÿ‘งโ€๐Ÿ‘ฆ Community

๐Ÿ“ˆ

+ 9.96%
Annual Growth

4 years average annual capital growth

๐Ÿ’ต

$ 500
Minimum Order

Due to regulatory requirements

๐ŸŒ

1
Pearlers Invested

Since January 2020

๐Ÿ‘‘ Overview

Key information
๐Ÿ”Ž Fund Overview

Cannon Resources Limited

๐Ÿ“ˆ Performance

Price History

+41.27%

1M

All Time

Graph

Table

Unsure how much or often to invest?
๐Ÿ—“๏ธ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out โ†’
๐Ÿ’ต Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out โ†’
โฑ๏ธ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out โ†’

๐Ÿ’ต Costs

๐Ÿ’ต

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

๐Ÿ’ผ

N/A
Management Fee

Included in unit price, not charged by Pearler

๐Ÿ’ธ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐Ÿ’ธ Net fee calculator

๐Ÿค“ Advanced information

Technical Info

๐Ÿ’ฐ Price*

$0.45

*Price may be up to 24 hours old

๐Ÿ‘ฉโ€๐Ÿ‘ฉโ€๐Ÿ‘ฆ Community Insights

How our community is investing

๐ŸŒ Pearlers invested in CNR

0

๐Ÿ“Š Total Capital Earnings

$-509.84

๐Ÿ”ƒ Average investment frequency

13 weeks

๐Ÿ’ต Average investment amount

$547

โฐ Last time a customer invested in CNR

1055 days
CNR investor breakdown
๐Ÿ’ต Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

Less than 50k

๐Ÿ‘ถ Age of investors

18 - 25

26 - 34

35 - 90

๐Ÿ™‹ Legal gender of investors

Female

Male

Pearlers who invest in CNR also invest in...

Betashares Global Sustainability Leaders ETF

ETHI

ETHI.AX was created on 2017-01-05 by BetaShares. The fund's investment portfolio concentrates primarily on total market equity. The fund aims to track the performance of an index (before fees and expenses) that includes a portfolio of large global stocks identified as Climate Leaders that have also passed screens to exclude companies with direct or significant exposure to fossil fuels or engaged in activities deemed inconsistent with responsible investment considerations.

๐Ÿ™Œ Performance (5Yr p.a)

12.43%

๐Ÿ“Š Share price

$16.88 AUD

โ›ณ๏ธ DIVERSIFIED

๐Ÿค– TECHNOLOGY

๐ŸŒ GLOBAL

๐Ÿ“ˆ HIGH PRICE GROWTH

Find Out More

Actinogen Medical Ltd. is a clinical stage Australian biotechnology company, which focuses on the development of novel treatments or cognitive impairment associated with neurological, psychiatric, and metabolic diseases due to raised cortisol. The company is headquartered in Sydney, New South Wales. The company went IPO on 2007-10-16. The firm is engaged in the development of a therapy for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol. The firm is engaged in the development of its lead compound, Xanamem, as a therapy for Alzheimerโ€™s Disease, Major Depressive Disorder, Fragile X Syndrome, and other neurological diseases where reducing cortisol inside brain cells could have a positive impact. Xanamemโ€™s mechanism of action is to block the production of cortisol inside cells through the inhibition of the 11B-HSD1 enzyme in the brain. Xanamem is designed to get into the brain after it is absorbed in the intestines upon swallowing its capsule. The company has studied 11B-HSD1 inhibition by Xanamem in approximately 300 volunteers and patients. The firm conducts a series of Phase II studies in multiple diseases to further confirm and characterize Xanamemโ€™s therapeutic potential.

๐Ÿ™Œ Performance (5Yr p.a)

10.00%

๐Ÿ“Š Share price

$0.03 AUD

๐Ÿ“ˆ HIGH PRICE GROWTH

๐Ÿงฌ BIOTECHNOLOGY

Cogstate Ltd. is a global cognitive science company, which engages in delivering software services to optimize the measurement of cognition in clinical trials, academic research, healthcare and brain injury. The company is headquartered in Melbourne, Victoria. The company went IPO on 2004-02-13. Its principal activities are the creation, validation, and commercialization of digital brain health assessments; and design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its segments include Clinical Trials, Healthcare, and Administration. In the Clinical Trials segment, the technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical, and biotechnology companies. In the Healthcare segment, the technology and associated services are being developed as a tool for primary care physicians and/or hospitals to assess cognitive decline.

๐Ÿ™Œ Performance (5Yr p.a)

42.50%

๐Ÿ“Š Share price

$2.50 AUD

๐Ÿฉบ HEALTH CARE

๐Ÿ“ˆ HIGH PRICE GROWTH

Flight Centre Travel Group Ltd. is engaged in providing travel retailing, wholesaling and corporate travel management services. The company is headquartered in Brisbane, Queensland and currently employs 12,411 full-time employees. The firm's principal activities consist of leisure travel retailing and corporate travel management, plus in-destination travel experience businesses including tour operations, hotel management, destination management companies (DMCs) and wholesaling. Its segments include Leisure, Corporate, and Other. The Leisure segment combines the retail storefront and online brands for retail customers, luxury travel brands Travel Associates and Scott Dunn, independent agents and complementary offerings. The Corporate segment includes the FCM brand, corporate traveler and other corporate customer brands. The Other segment includes Brisbane-based and other support businesses, including Supply, that support the global network and also includes travel management services which incorporate touring, ground-handling and hotels. Its brands include Flight Centre, Aunt Betty, ignite, and Scott Dunn, among others.

๐Ÿ™Œ Performance (5Yr p.a)

-2.37%

๐Ÿ“Š Share price

$12.00 AUD

๐Ÿจ HOTELS, RESTAURANTS & LEISURE

HACK.AX was created on 2016-08-30 by BetaShares. The fund's investment portfolio concentrates primarily on theme equity. The fund aims to track the performance of an index (before fees and expenses) that provides exposure to the leading companies in the global cybersecurity sector.

๐Ÿ™Œ Performance (5Yr p.a)

20.78%

๐Ÿ“Š Share price

$15.68 AUD

๐Ÿ“ˆ HIGH PRICE GROWTH

๐Ÿค– TECHNOLOGY

๐Ÿ‡ฆ๐Ÿ‡บ EX AUSTRALIA

Want more shares? Try these...

Chorus Ltd. operates as a telecommunications infrastructure company. The Companyโ€™s product portfolio includes a range of wholesale broadband, data, and voice services across a mix of regulated and commercial products. The company operates in the segment of nationwide fixed-line communications infrastructure. Its services include fiber and copper connections, providing access to the fixed-line network for Internet connectivity. The value-added network services enhance access to the fixed-line network for improved Internet connections through backhaul and handover link services, enabling connectivity across wider areas. Infrastructure services offer physical storage and site-sharing rental options for the co-location of third-party or shared assets. Field services cover installation, wiring, and consultation support. The Companyโ€™s subsidiary is Chorus New Zealand Limited.

๐Ÿ™Œ Performance (5Yr p.a)

0.71%

๐Ÿ“Š Share price

$8.16 AUD

๐Ÿ“ž COMMUNICATIONS

๐Ÿ“Š Share price

$0.02 AUD